Profil
Ingrid Goldberg is currently Vice President-Investor Relations at Medtronic Plc since 2025.
Former roles include Director-Investor Relations at ABIOMED, Inc. from 2014 to 2019, Vice President-Investor Relations at bluebird bio, Inc. from 2020 to 2021, and Vice President-Finance & Investor Relations at NovoCure Ltd. Education includes undergraduate studies at Princeton University and an MBA from MIT Sloan School of Management.
Aktive Positionen von Ingrid Goldberg
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDTRONIC PLC | Investor Relations Kontakt | 08.12.2025 |
Ehemalige bekannte Positionen von Ingrid Goldberg
| Unternehmen | Position | Ende |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Investor Relations Kontakt | 01.06.2021 |
| ABIOMED, INC. | Investor Relations Kontakt | 01.12.2019 |
| NOVOCURE LIMITED | Investor Relations Kontakt | - |
Ausbildung von Ingrid Goldberg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
ABIOMED, Inc.
ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Plc
Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
















